Selected research
Industry Research
Voltaren Industry Research Report 2026
Market perspective
The global Voltaren market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Voltaren is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Voltaren is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Voltaren is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Voltaren include Endo Pharmaceuticals, Enovachem Pharmaceuticals, Hainan Quanxing Pharmaceutical, Iroko Pharmaceuticals, Jewim Pharmaceutical, Supor South Ocean, GSK and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Voltaren market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Voltaren Market by Company
Endo Pharmaceuticals
Enovachem Pharmaceuticals
Hainan Quanxing Pharmaceutical
Iroko Pharmaceuticals
Jewim Pharmaceutical
Supor South Ocean
GSK
Novartis
Voltaren Segment by Type
Injection
Tablet
Spray
Gel
Capsule
Voltaren Segment by Application
Elderly
Adults
Voltaren Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Voltaren market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Voltaren and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Voltaren.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Voltaren manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Voltaren by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Voltaren in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablet
- Spray
- Gel
- Capsule
Applications
- Elderly
- Adults
Companies covered
- Endo Pharmaceuticals
- Enovachem Pharmaceuticals
- Hainan Quanxing Pharmaceutical
- Iroko Pharmaceuticals
- Jewim Pharmaceutical
- Supor South Ocean
- GSK
- Novartis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Voltaren Market Size (2021-2032)
- 2.2.2 Global Voltaren Sales (2021-2032)
- 2.2.3 Global Voltaren Market Average Price (2021-2032)
- 2.3 Voltaren by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Tablet
- 2.3.4 Spray
- 2.3.5 Gel
- 2.3.6 Capsule
- 2.4 Voltaren by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Elderly
- 2.4.3 Adults
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Voltaren Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Voltaren Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Voltaren Revenue of Manufacturers (2021-2026)
- 3.4 Global Voltaren Average Price by Manufacturers (2021-2026)
- 3.5 Global Voltaren Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Voltaren, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Voltaren, Product Type & Application
- 3.8 Global Manufacturers of Voltaren, Established Date
- 3.9 Global Voltaren Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Endo Pharmaceuticals
- 4.1.1 Endo Pharmaceuticals Company Information
- 4.1.2 Endo Pharmaceuticals Business Overview
- 4.1.3 Endo Pharmaceuticals Voltaren Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Endo Pharmaceuticals Voltaren Product Portfolio
- 4.1.5 Endo Pharmaceuticals Recent Developments
- 4.2 Enovachem Pharmaceuticals
- 4.2.1 Enovachem Pharmaceuticals Company Information
- 4.2.2 Enovachem Pharmaceuticals Business Overview
- 4.2.3 Enovachem Pharmaceuticals Voltaren Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Enovachem Pharmaceuticals Voltaren Product Portfolio
- 4.2.5 Enovachem Pharmaceuticals Recent Developments
- 4.3 Hainan Quanxing Pharmaceutical
- 4.3.1 Hainan Quanxing Pharmaceutical Company Information
- 4.3.2 Hainan Quanxing Pharmaceutical Business Overview
- 4.3.3 Hainan Quanxing Pharmaceutical Voltaren Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hainan Quanxing Pharmaceutical Voltaren Product Portfolio
- 4.3.5 Hainan Quanxing Pharmaceutical Recent Developments
- 4.4 Iroko Pharmaceuticals
- 4.4.1 Iroko Pharmaceuticals Company Information
- 4.4.2 Iroko Pharmaceuticals Business Overview
- 4.4.3 Iroko Pharmaceuticals Voltaren Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Iroko Pharmaceuticals Voltaren Product Portfolio
- 4.4.5 Iroko Pharmaceuticals Recent Developments
- 4.5 Jewim Pharmaceutical
- 4.5.1 Jewim Pharmaceutical Company Information
- 4.5.2 Jewim Pharmaceutical Business Overview
- 4.5.3 Jewim Pharmaceutical Voltaren Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jewim Pharmaceutical Voltaren Product Portfolio
- 4.5.5 Jewim Pharmaceutical Recent Developments
- 4.6 Supor South Ocean
- 4.6.1 Supor South Ocean Company Information
- 4.6.2 Supor South Ocean Business Overview
- 4.6.3 Supor South Ocean Voltaren Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Supor South Ocean Voltaren Product Portfolio
- 4.6.5 Supor South Ocean Recent Developments
- 4.7 GSK
- 4.7.1 GSK Company Information
- 4.7.2 GSK Business Overview
- 4.7.3 GSK Voltaren Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GSK Voltaren Product Portfolio
- 4.7.5 GSK Recent Developments
- 4.8 Novartis
- 4.8.1 Novartis Company Information
- 4.8.2 Novartis Business Overview
- 4.8.3 Novartis Voltaren Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Novartis Voltaren Product Portfolio
- 4.8.5 Novartis Recent Developments
5 Global Voltaren Market Scenario by Region
- 5.1 Global Voltaren Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Voltaren Sales by Region: 2021-2032
- 5.2.1 Global Voltaren Sales by Region: 2021-2026
- 5.2.2 Global Voltaren Sales by Region: 2027-2032
- 5.3 Global Voltaren Revenue by Region: 2021-2032
- 5.3.1 Global Voltaren Revenue by Region: 2021-2026
- 5.3.2 Global Voltaren Revenue by Region: 2027-2032
- 5.4 North America Voltaren Market Facts & Figures by Country
- 5.4.1 North America Voltaren Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Voltaren Sales by Country (2021-2032)
- 5.4.3 North America Voltaren Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Voltaren Market Facts & Figures by Country
- 5.5.1 Europe Voltaren Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Voltaren Sales by Country (2021-2032)
- 5.5.3 Europe Voltaren Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Voltaren Market Facts & Figures by Country
- 5.6.1 Asia Pacific Voltaren Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Voltaren Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Voltaren Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Voltaren Market Facts & Figures by Country
- 5.7.1 South America Voltaren Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Voltaren Sales by Country (2021-2032)
- 5.7.3 South America Voltaren Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Voltaren Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Voltaren Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Voltaren Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Voltaren Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Voltaren Sales by Type (2021-2032)
- 6.1.1 Global Voltaren Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Voltaren Sales Market Share by Type (2021-2032)
- 6.2 Global Voltaren Revenue by Type (2021-2032)
- 6.2.1 Global Voltaren Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Voltaren Revenue Market Share by Type (2021-2032)
- 6.3 Global Voltaren Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Voltaren Sales by Application (2021-2032)
- 7.1.1 Global Voltaren Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Voltaren Sales Market Share by Application (2021-2032)
- 7.2 Global Voltaren Revenue by Application (2021-2032)
- 7.2.1 Global Voltaren Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Voltaren Revenue Market Share by Application (2021-2032)
- 7.3 Global Voltaren Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Voltaren Value Chain Analysis
- 8.1.1 Voltaren Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Voltaren Production Mode & Process
- 8.2 Voltaren Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Voltaren Distributors
- 8.2.3 Voltaren Customers
9 Global Voltaren Analyzing Market Dynamics
- 9.1 Voltaren Industry Trends
- 9.2 Voltaren Industry Drivers
- 9.3 Voltaren Industry Opportunities and Challenges
- 9.4 Voltaren Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst